Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply
J Addict Med
.
2020 Dec;14(6):518-519.
doi: 10.1097/ADM.0000000000000651.
Authors
Joji Suzuki
1
,
Jennifer A Johnson
,
Mary W Montgomery
2
,
Margaret C Hayden
3
,
Christin N Price
4
,
Daniel A Solomon
2
,
Jane M Liebschutz
5
,
Jeffrey L Schnipper
6
,
Roger D Weiss
7
Affiliations
1
Department of Psychiatry, Brigham and Women's Hospital, Boston, MA.
2
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.
3
Primary Care Residency, Brigham and Women's Hospital, Boston, MA.
4
Brigham and Women's Physicians Organization, Boston, MA.
5
Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA.
6
Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA.
7
Division of Drug and Alcohol Abuse, McLean Hospital, Belmont, MA.
PMID:
32187110
PMCID:
PMC7487051
DOI:
10.1097/ADM.0000000000000651
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Analgesics, Opioid / therapeutic use
Humans
Opioid-Related Disorders* / drug therapy
Substances
Analgesics, Opioid
Grants and funding
K23 DA042326/DA/NIDA NIH HHS/United States
K24 DA022288/DA/NIDA NIH HHS/United States